title: Continuous positive airway pressure therapy in sleep apnoea.
abstract: Sleep apnoea is associated with increased mortality and morbidity. The treatment goal is to reduce the neurocognitive and cardiovascular sequelae. CPAP therapy in sleep apnoea is discussed in two parts in the article. The first part will consider CPAP therapy in the more common form of sleep apnoea (i.e. obstructive or mixed sleep apnoea) and the second part will consider CPAP therapy in central sleep apnoea. Alternative positive airway pressure modalities are discussed. CPAP therapy has been extensively studied and it remains the mainstay of treatment in obstructive sleep apnoea, as it is still the most consistently efficacious and safe option. However, its major disadvantage is that it does not confer a cure to this disorder and hence therapy is generally life long with its usual treatment compliance problems. As such, there are continuous improvement strategies. The role of CPAP therapy in central sleep apnoea is more limited. There has been increasing data on the beneficial effect of CPAP on central sleep apnoea/Cheyne-Stokes respiration in congestive heart failure. Evidence for CPAP therapy in sleep apnoea has evolved significantly over the last decade. However, more research and publication of large-scale long-term randomized trials of treatment in sleep apnoea to assess patient-orientated outcomes and preferences are necessary.
authors.affiliation: Sleep Disorders Unit, Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore. gm3hal@sgh.gov.sg
authors.forename: Anne A L
authors.initials: AA
authors.lastname: Hsu
authors.forename: Constance
authors.initials: C
authors.lastname: Lo
mesh_terms: D045422:Continuous Positive Airway Pressure / Q000379:methods; D006801:Humans; D010349:Patient Compliance; D012891:Sleep Apnea Syndromes / Q000628:therapy*; D020182:Sleep Apnea, Central / Q000628:therapy; D020181:Sleep Apnea, Obstructive / Q000628:therapy; D016896:Treatment Outcome